Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients

This study has been completed.
Sponsor:
Information provided by:
Biokine Therapeutics Ltd
ClinicalTrials.gov Identifier:
NCT01010880
First received: November 9, 2009
Last updated: June 9, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)